|
所属 |
附属病院 総合診療医センター |
|
研究室電話 |
018-884-6185 |
|
研究室FAX |
018-884-6450 |
平澤 暢史 (ヒラサワ ノブヒサ)
HIRASAWA Nobuhisa
|
|
|
研究等業績 【 表示 ／ 非表示 】
-
Suzuki Y.
Therapeutic Apheresis and Dialysis ( Therapeutic Apheresis and Dialysis ) 27 ( 6 ) 1028 - 1034 2023年12月 [査読有り]
研究論文（学術雑誌）
-
Makyoyokukanto use in patients with painful afflictions
Hirasawa Nobuhisa, Nakae Hajime, Tanaka Hidenori, Irie Yasuhito
Personalized Medicine Universe ( 一般社団法人 国際個別化医療学会 ) 12 ( 0 ) 16 - 22 2023年11月 [査読有り]
研究論文（学術雑誌）
<p>Aim: Makyoyokukanto (MKYK) is a traditional Japanese medicine used for relieving arthralgia, neuralgia, and myalgia. However, the effectiveness and safety of MKYK remains unclear. In this study, we assessed the effectiveness of MKYK in patients with painful afflictions.</p><p>Methods: One hundred and sixty-three patients (42 men and 121 women) with painful afflictions were recruited into the study. All participants were treated using non-invasive methods and administered MKYK. The effectiveness of MKYK was assessed following administration by evaluating the need for NSAIDs or other medication. In addition, adverse reactions were monitored.</p><p>Results: 85.9% of the patients were effectively treated with MKYK. Comorbidities were present in 52.8% of the study participants. The median duration of MKYK treatment was 14 days (2–364 days). The adverse event rate was 1.2%. The adverse events were insomnia caused by Ephedra herb and pseudoaldosteronism by Glycyrrhiza root. All symptoms improved after MKYK withdrawal.</p><p>Conclusion: The adverse event rate associated with MKYK use was low, and its onset was relatively rapid. This adverse event rate can be further reduced by focusing on the pharmacological action of Ephedra herb and Glycyrrhiza root. This study suggests that MKYK can be used more widely for painful afflictions.</p>
-
Retrospective study on efficacy and safety of Jidabokuippo in real-world clinical practice
Nakae Hajime, Kitamura Toshiharu, Satoh Kasumi, Hirasawa Nobuhisa, Kameyama Koumei, Nara Tasuku, Suzuki Yuya, Yoshida Kenji, Maeno Kyohei, Tsuchida Hideomi, Yasuda Takuto, Saruta Rio, Okuyama Manabu
Personalized Medicine Universe ( 一般社団法人 国際個別化医療学会 ) 13 ( 0 ) 38 - 45 2024年11月
<p>Purpose: Few studies have investigated the treatment outcomes and adverse events after using jidabokuippo (JDI), including the concomitant use of Kampo prescriptions and analgesics. In this study, we retrospectively analyzed the efficacy and safety of JDI in real-world clinical practice.</p><p>Methods: The study included 306 patients who were treated with JDI. Treatment outcomes and adverse events were compared according to age, sex, presence or absence of comorbidities, concomitant use of Kampo prescriptions and analgesics, daily dose of JDI, duration of administration, and the starting time of administration. The patients were divided into two groups: effective and ineffective.</p><p>Results: Concomitant use of Kampo prescriptions and analgesics was observed in 14.1% and 58.2% of the patients, respectively. The efficacy rate of JDI was 97.7%. The duration of JDI treatment in the analgesic group was significantly longer than that in the non-analgesic group (<i>p</i> = 0.0100). None of the patients reported any adverse events.</p><p>Conclusion: The efficacy rate of JDI was as high as 97.7% and no adverse events were observed. Adverse events can be prevented by being cautious of the side effects of Kampo prescriptions. However, the rate of concomitant use of analgesics was high, and the effects of reducing the dosage and frequency of analgesics remains to be determined.</p>
-
治療 当科における自家皮膚細胞移植用キット(RECELL®自家細胞採取・非培養細胞懸濁液作製キット)の使用経験
佐藤 晴香, 能登 舞, 石塚 大, 赤坂 有妃子, 伊藤 拓, 小松田 恵理子, 熊谷 史子, 堀江 咲織, 佐藤 貴彦, 佐藤 有里子, 東海林 怜, 豊島 あや, 亀山 孔明, 平澤 暢史, 中永 士師明, 河野 通浩
皮膚科の臨床 ( 金原出版 ) 66 ( 8 ) 1066 - 1070 2024年07月
-
Yoshida K.
Therapeutic Apheresis and Dialysis ( Therapeutic Apheresis and Dialysis ) 2024年
-
Satoh K.
Journal of Emergency Medicine ( Journal of Emergency Medicine ) 62 ( 5 ) e98 - e100 2022年05月
-
Safety of jidabokuippo administration based on adverse event rate
Kitamura T.
Traditional and Kampo Medicine ( Traditional and Kampo Medicine ) 9 ( 1 ) 18 - 24 2022年04月